KEY CONSIDERATIONS FOR EVALUATING REAL-WORLD EVIDENCE IN SUPPORT OF FDA REGULATORY DECISION-MAKING

被引：0
|
作者：
Li, Jie [1 ]
机构：
[1] FDA CDER Off Surveillance & Epidemiol, Silver Spring, MD USA
来源：
INNOVATION IN AGING | 2022年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [21] Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making
    Franklin, Jessica M.
    Glynn, Robert J.
    Martin, David
    Schneeweiss, Sebastian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (04) : 867 - 877
  • [22] Regulatory decision-making meets the real world
    Hohman, Ryan
    Shea, Michael
    Kozak, Marina
    Roberts, Samantha
    Allen, Jef
    Sigal, Ellen
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (313)
  • [23] Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence
    Hernandez, Rohini K.
    Critchlow, Cathy W.
    Dreyer, Nancy
    Lash, Timothy L.
    Reynolds, Robert F.
    Sorensen, Henrik T.
    Lange, Jeff L.
    Gatto, Nicolle M.
    Sobel, Rachel E.
    Lai, Edward Chia-Cheng
    Schoonen, Marieke
    Brown, Jeffrey S.
    Christian, Jennifer B.
    Brookhart, M. Alan
    Bradbury, Brian D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [24] Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions
    Akhras, Kasem S.
    Alsheikh-Ali, Alawi A.
    Kabbani, Samer
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (03) : 245 - 250
  • [25] Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas
    Demetri, George D.
    Stacchiotti, Silvia
    ONCOLOGY, 2021, 99 (SUPPL 1) : 3 - 7
  • [26] Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project
    Franklin, Jessica M.
    Pawar, Ajinkya
    Martin, David
    Glynn, Robert J.
    Levenson, Mark
    Temple, Robert
    Schneeweiss, Sebastian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 817 - 826
  • [27] Best Evidence to Support Regulatory Decision-Making
    Blake, K.
    Fitt, H.
    Hidalgo-Simon, A.
    Arlett, P.
    DRUG SAFETY, 2013, 36 (09) : 866 - 866
  • [28] Real-World Evidence to Support EU Regulatory Decision Making-Results From a Pilot of Regulatory Use Cases
    Prilla, Stefanie
    Groeneveld, Sophie
    Pacurariu, Alexandra
    Restrepo-Mendez, Maria Clara
    Verpillat, Patrice
    Torre, Carla
    Gartner, Christian
    Mol, Peter G. M.
    Naumann-Winter, Frauke
    Breen, Kieran C.
    Gault, Nathalie
    Gross-Martirosyan, Liana
    Benchetrit, Sylvie
    Aylward, Brian
    Stoyanova-Beninska, Violeta
    O'Donovan, Maura
    Straus, Sabine
    Kjaer, Jesper
    Arlett, Peter
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (05) : 1188 - 1197
  • [29] Smog, Cognition and Real-World Decision-Making
    Chen, Xi
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2019, 8 (02): : 76 - 80
  • [30] EXAMINE THE USE OF REAL-WORLD EVIDENCE TO SUPPORT FDA DECISION-MAKING FOR NEW DRUG APPLICATIONS AND BIOLOGICS LICENSE APPLICATIONS FROM 2021 TO 2022
    Cheng, C. H.
    Farley, J. F.
    VALUE IN HEALTH, 2024, 27 (06) : S216 - S216
12345